Olive AI
Healthcare RPA and revenue cycle automation company. Once $4B+ unicorn; shut down October 2023 after revenue couldn't justify valuation.
RIP Olive AI
Shut down · October 2023
Olive AI was the healthcare automation startup that hit a $4B valuation in mid-2021 — the highest-valued healthcare AI company at peak hype. Founded by Sean Lane in 2012 in Columbus, Olive offered RPA-based automation for hospital revenue cycle work. Aggressive M&A expanded surface area faster than the tech could deliver. By 2022 customers complained 'Olive AI' was RPA marketing rather than real AI. The company sold core revenue-cycle assets to Waystar and Humata Health in October 2023 and wound down. Olive became the canonical example of the 2023 healthcare AI valuation reset.
Overview
Olive AI: Healthcare AI Automation (Deceased)
Olive AI was Healthcare RPA and revenue cycle automation platform founded 2012. Olive AI shut down its core operations in October 2023 after failing to translate its $4 billion valuation into commercial traction at hospitals. The company had grown rapidly during 2020-2022 with aggressive M&A, but customers complained that the AI offerings were RPA wrapped in marketing rather than genuine workflow automation. Core revenue cycle assets were sold to Waystar and Humata Health; the rest of the company was wound down.
Key Features
- Healthcare RPA and revenue cycle automation platform founded 2012
- Reached $4 billion+ valuation at peak in mid-2021
- Targeted hospital revenue cycle automation: prior auth, claims, eligibility
- Acquired multiple smaller competitors during 2020-2022 expansion
- Sold core assets to Waystar and Humata Health October 2023
- Cited shrinking healthcare AI capital as key reason for wind-down
- Founded by Sean Lane in Columbus, Ohio
Historical Use Case
Historical reference for the 2020-2022 healthcare AI hype cycle. Olive was the highest-valued healthcare AI startup before the 2023 reset taught the market that hospital ops automation requires deeper workflow integration than RPA alone.
What Happened to Olive AI
Olive AI shut down its core operations in October 2023 after failing to translate its $4 billion valuation into commercial traction at hospitals. The company had grown rapidly during 2020-2022 with aggressive M&A, but customers complained that the AI offerings were RPA wrapped in marketing rather than genuine workflow automation. Core revenue cycle assets were sold to Waystar and Humata Health; the rest of the company was wound down.
FAQ
Q: Why did Olive AI shut down? A: Inability to translate $4B peak valuation into recurring revenue. Customers reported that AI features were RPA without deeper workflow integration.
Q: Where did the assets go? A: Revenue cycle and prior-auth assets sold to Waystar and Humata Health; rest wound down.
Q: Peak valuation? A: $4 billion+ in mid-2021 — highest healthcare AI unicorn before the 2023 reset.
Q: Founder? A: Sean Lane founded Olive in Columbus, Ohio in 2012.
tl;dr
Healthcare RPA unicorn at $4B peak. Shut Oct 2023 after revenue couldn't justify valuation. Assets sold.
Related
Looking for more options? Browse the Healthcare directory or read our best AI healthcare tools listicle. Olive AI is also tracked on Crunchbase.
Why Use Olive AI
